{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2023", "item": "https://www.patentleaderboard.com/2023/"}, {"@type": "ListItem", "position": 3, "name": "Array Biopharma", "item": "https://www.patentleaderboard.com/2023/company/array-biopharma"}, {"@type": "ListItem", "position": 4, "name": "Li Ren", "item": "https://www.patentleaderboard.com/2023/inventor/fl:li_ln:ren-2"}]}

Home › 2023 › Array Biopharma › Li Ren

LR

Li Ren — 9 Patents in 2023

ABArray Biopharma: 4 patents #3 of 68Top 5%

Pfizer: 2 patents #15 of 301Top 5%

Indianapolis, IN: #9 of 474 inventorsTop 2%

Indiana: #23 of 3,533 inventorsTop 1%

Overall (2023): #9,904 of 537,848Top 2%

9 Patents 2023

Issued Patents 2023

Showing 1–9 of 9 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11851434	Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors	Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more	2023-12-26
11807649	Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2	Joseph P. Lyssikatos, Samuel Kintz, Qiang Su	2023-11-07	$7,128,000
11807638	5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases	Joseph P. Lyssikatos, Samuel Kintz	2023-11-07
11802127	3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors	Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Mark Laurence Boys, Joshua Ryan Dahlke +3 more	2023-10-31	$284,263,000
11767321	5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases	Joseph P. Lyssikatos, Samuel Kintz	2023-09-26
11691973	3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors	Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Sydney Taylor BLANCHE, Mark Laurence Boys +9 more	2023-07-04
11648243	Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more	2023-05-16
11634409	Compounds for the treatment of BRAF-associated diseases and disorders	Patrick Barbour, Katie Keaton BROWN, Adam Cook, Erik James Hicken, Dean Russell Kahn +7 more	2023-04-25
11603374	Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors	James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +6 more	2023-03-14